Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Amneal Pharmaceuticals, Inc. - Class A Common Stock (NQ:AMRX)

7.830 +0.010 (+0.13%)

Streaming Delayed Price Updated: 4:00 PM EDT, Aug 1, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,505,511
Open	7.720
Bid (Size)	7.200 (30)
Ask (Size)	8.450 (2)
Prev. Close	7.820
Today's Range	7.665 - 7.840
52wk Range	6.500 - 9.475
Shares Outstanding	1,000
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Q1 Earnings Highs And Lows: Amneal (NASDAQ:AMRX) Vs The Rest Of The Generic Pharmaceuticals Stocks

July 28, 2025

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the generic pharmaceuticals industry, including Amneal (NASDAQ:AMRX) and its peers.

Via StockStory

Amneal Announces Proposed Refinancing of Existing Credit Agreement, including Private Offering of Senior Secured Notes Due 2032

July 21, 2025

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

Performance

YTD	+0.9%	+0.9%
1 Month	-7.0%	-7.0%
3 Month	+3.8%	+3.8%
6 Month	-4.3%	-4.3%
1 Year	+12.0%	+12.0%

More News

Amneal Reports Certain Preliminary Second Quarter 2025 Financial Results

July 21, 2025

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

3 Profitable Stocks with Warning Signs

July 21, 2025

Via StockStory

Amneal to Report Second Quarter 2025 Results on August 5, 2025

July 09, 2025

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

1 Small-Cap Stock to Consider Right Now and 2 to Keep Off Your Radar

July 08, 2025

Via StockStory

Amneal Highlights Positive Topline Results from Confirmatory Clinical Study of Biosimilar Candidate to XOLAIR(R) (omalizumab), Developed by Kashiv BioSciences

June 25, 2025

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

Amneal Receives U.S. FDA Approval for Prednisolone Acetate Ophthalmic Suspension

June 12, 2025

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

Goldman Sachs Bullish On Branded Drug Upside At Teva: What About Viatris?

June 06, 2025

Via Benzinga

3 of Wall Street’s Favorite Stocks in the Doghouse

June 05, 2025

Via StockStory

Amneal Recalls Three Lots Of UTI Drug Over Concerns of Microbial Contamination: Retail Sticks To Bearish Territory

June 04, 2025

Via Stocktwits

Amneal to Participate at Upcoming Investor Conferences in June

May 29, 2025

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

AMRX Q1 Earnings Call: Miss on Revenue, Margin Expansion, and Product Pipeline Progress

May 16, 2025

Via StockStory

Amneal Gets FDA Nod For Self-Administrable Migraine Injection

May 15, 2025

Via Stocktwits

Amneal Receives U.S. FDA Approval for Brekiya® (dihydroergotamine mesylate) injection for the Acute Treatment of Migraine and Cluster Headaches in Adults

May 15, 2025

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

3 Russell 2000 Stocks in Hot Water

May 13, 2025

Via StockStory

Amneal and Apiject to Expand Sterile and Blow-Fill-Seal (BFS) Capabilities for Advanced Pharmaceutical Manufacturing in the U.S.

May 08, 2025

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

3 Value Stocks in Hot Water

May 08, 2025

Via StockStory

3 Small-Cap Stocks Facing Headwinds

May 07, 2025

Via StockStory

Drug Maker Amneal Highlights Strong Commercial Uptake For Parkinson's Drug But Q1 Earnings Are Mixed

May 02, 2025

Via Benzinga

Amneal (NASDAQ:AMRX) Misses Q1 Sales Targets, Stock Drops 11.3%

May 02, 2025

Via StockStory

Amneal Reports First Quarter 2025 Financial Results

May 02, 2025

From Amneal Pharmaceuticals, Inc.

Via Business Wire

Earnings Scheduled For May 2, 2025

May 02, 2025

Via Benzinga

Examining the Future: Amneal Pharmaceuticals's Earnings Outlook

May 01, 2025

Via Benzinga

Amneal (AMRX) To Report Earnings Tomorrow: Here Is What To Expect

May 01, 2025

Via StockStory

Frequently Asked Questions

Is Amneal Pharmaceuticals, Inc. - Class A Common Stock publicly traded?

Yes, Amneal Pharmaceuticals, Inc. - Class A Common Stock is publicly traded.

What exchange does Amneal Pharmaceuticals, Inc. - Class A Common Stock trade on?

Amneal Pharmaceuticals, Inc. - Class A Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Amneal Pharmaceuticals, Inc. - Class A Common Stock?

The ticker symbol for Amneal Pharmaceuticals, Inc. - Class A Common Stock is AMRX on the Nasdaq Stock Market

What is the current price of Amneal Pharmaceuticals, Inc. - Class A Common Stock?

The current price of Amneal Pharmaceuticals, Inc. - Class A Common Stock is 7.830

When was Amneal Pharmaceuticals, Inc. - Class A Common Stock last traded?

The last trade of Amneal Pharmaceuticals, Inc. - Class A Common Stock was at 08/01/25 04:00 PM ET

What is the market capitalization of Amneal Pharmaceuticals, Inc. - Class A Common Stock?

The market capitalization of Amneal Pharmaceuticals, Inc. - Class A Common Stock is 7.83K

How many shares of Amneal Pharmaceuticals, Inc. - Class A Common Stock are outstanding?

Amneal Pharmaceuticals, Inc. - Class A Common Stock has 8K shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.